Arthur Suckow
Principal investigator, leads DTx Pharma, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$1.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 30, 2020 | NIH | SBIR Phase I Development of PMP22 siRNA Conjugates for Treatment of Charcot-Marie-Tooth Disease Type 1A | $388K | DTx Pharma, Inc. |
| Sep 1, 2020 | NIH | STTR Phase I Reversal of Tau Pathology with MSUT2 siRNA Conjugates | $313K | DTx Pharma, Inc. with SEATTLE INST FOR BIOMEDICAL/CLINICAL RES |
| Sep 15, 2019 | NIH | SBIR Phase I Generation of potent, safe and deliverable human Tau targeting siRNA for treatment of Tauopathies | $225K | DTx Pharma, Inc. |
| Apr 2, 2019 | NIH | SBIR Phase I Systemic Characterization of Novel Lipidated siRNA Conjugates | $322K | DTx Pharma, Inc. |
| Apr 2, 2019 | NIH | SBIR Phase I Development of Conjugated Oligonucleotide Therapeutics for Neuronal Disease | $301K | DTx Pharma, Inc. |
1 patents as inventor
- US DTx Pharma, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,324
Awards as PI#417
Patents#273
Companies
- DTx Pharma, Inc.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.